Over Cabrera
2Patents
1h-index
10Co-inventors
31Inventor score
Filing activity: Jul 22, 2019 → Jul 22, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11084861B2 | GIP/GLP1 co-agonist compounds | Human Necessities | 3 | Active |
| US12295987B2 | Method of using a GIP/GLP1 co-agonist for diabetes | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.